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To study molecular aspects of cytotoxicity of the anticancer drug b-D-glucose-ifosfamide mustard we investigated the
potential of the agent to induce apoptosis and DNA breakage. Since b-D-glucose-ifosfamide mustard generates DNA
interstrand crosslinks, we used as an in vitro model system a pair of isogenic Chinese hamster V79 cells differing in their
sensitivity to crosslinking agents. CL-V5B cells are dramatically more sensitive (30-fold based on D10 values) to the cytotoxic
effects of b-D-glucose-ifosfamide mustard as compared to parental V79B cells. After 48 h of pulse-treatment with the agent,
sensitive cells but not the resistant parental line undergo apoptosis and necrosis, with apoptosis being the predominant form
of cell death (70 and 20% of apoptosis and necrosis, respectively). Apoptosis increased as a function of dose and was
accompanied by induction of DNA double-strand breaks in the hypersensitive cells. Furthermore, a strong decline in the level
of Bcl-2 protein and activation of caspases-3, -8 and -9 were observed. The resistant parental cells were refractory to all these
parameters. Bcl-2 decline in the sensitive cells preceded apoptosis, and transfection-mediated overexpression of Bcl-2
protected at least in part from apoptosis. From the data we hypothesize that non-repaired crosslinks induced by b-D-glucose-
ifosfamide mustard are transformed into double-strand breaks which trigger apoptosis via a Bcl-2 dependent pathway.
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The newly developed anticancer agent b-D-glucose-ifosfamide
mustard (b-D-Glc-IPM) is the glucose-bound form of ifosfamide
mustard. The glucose moiety coupled to IPM leads to drug
stabilization and preferential uptake of the compound by tumour
cells via the Na
+-D-glucose cotransporter SAAT1 (Veyhl et al,
1998). Once inside the cell the drug is cleaved preferentially by
intracellular glucosidases to form the ultimate cytostatic drug
ifosfamide mustard (Seker et al, 1996). It has previously been
shown that treatment of MCF-7 cells with b-D-Glc-IPM leads
to activation of poly(ADP-ribose) polymerase (Seker et al,
2000). In the same study, by using an in vivo model system
consisting of isogenic cell lines deﬁcient and proﬁcient for either
O
6-methylguanine-DNA methyltransferase (MGMT) or crosslink
repair, it could be demonstrated that the most critical cytotoxic
lesions caused by b-D-Glc-IPM are very likely to be DNA cross-
links (Seker et al, 2000). The cytotoxic pathway evoked by b-D-
Glc-IPM has not been elucidated so far. As for many other anti-
neoplastic agents, cytotoxicity of this chemotherapeutic drug
could be due to necrosis and/or apoptosis. Apotosis is character-
ized by a cascade-like activation of intracellular cystein-proteases
(i.e. caspases). Caspases pre-exist as zymogens and are activated
by proteolytic cleavage by other caspases or by autocatalysis.
Distinct caspase cascades are involved in receptor-mediated vs
chemical-induced apoptosis (Sun et al, 1999). Drug-induced
apoptosis is often mediated by the mitochondrial pathway lead-
ing to activation of the initiator caspase-9 which in turn
activates the effector caspases-3 and -7. Active caspase-3 has
several substrates, amongst others ICAD (inhibitor of caspase-
activated DNase) (Enari et al, 1998) and the anti-apoptotic
protein Bcl-2 (Cheng et al, 1997). Bcl-2 forms heterodimers with
the proapoptotic protein Bax and competes with the formation
of the channel forming Bax-Bax homodimers. It is hypothesized
that the ratio between Bcl-2 and the proapoptotic protein is
crucial in determining whether the mitochondria-mediated apop-
totic pathway is activated or not (for review, Allen et al, 1998).
Thus, overexpression of Bcl-2 is expected to result in increased
cell survival by preventing cells from undergoing DNA damage-
induced apoptosis, whereas decreased expression will favour the
onset of the apoptotic machinery. This has indeed been found
to be true for several experimental systems in which apoptosis
was found to be triggered by non-repaired DNA damage, such
as DNA-alkylation repair deﬁcient cells (Ochs and Kaina, 2000).
The aim of the present study was to investigate the mechanistic
basis of the cytotoxic effect of the chemotherapeutic drug b-D-Glc-
IPM. Since this drug causes cytotoxicity very likely by inducing
DNA crosslinks (Seker et al, 2000), parameters determining cell death
were examined by comparing the response of cells that are hypersen-
sitive to crosslinking agents (CL-V5B cells) with the corresponding
parental cell line (V79). We show that CL-5B cells respond with a
much higher frequency of apoptosis than the parental cells. Apoptosis
was related to DNA breakage, Bcl-2 decline and caspase activation.
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www.bjcancer.comTherefore, the data support the view that non-repaired DNA cross-
links efﬁciently trigger the mitochondrial damage pathway via the
formation of DNA strand breaks.
MATERIALS AND METHODS
Cell culture
CL-V5B cells have been generated by mutagenizing V79 Chinese
hamster cells (the line V79B) with ethylnitrosourea and selecting
for sensitivity to mitomycin C (Telleman et al, 1995). All cells were
grown in DMEM/F-12 (Gibco, BRL) containing 5% foetal calf
serum. Incubations were at 378C in a humiﬁed 7% CO2 atmo-
sphere. Adherent cells were detached with 0.25% trypsin at 378C.
Mutagen treatment
Cells were treated for 1 h with b-D-Glc-IPM (Asta-Medica, Frank-
furt, Germany) which was freshly solved in PBS by addition of the
agent to the medium. After treatment at 378C, cells were washed
with PBS, new medium was added and cells were analyzed at the
indicated post-exposure times.
Colony formation
400–500 cells were seeded into 5-cm dishes. After 6 h, when the
cells became adherent, they were treated with b-D-Glc-IPM for
1 h at the indicated concentrations. After incubation, cells were
washed with PBS and left for 1 week in the incubator. Colonies
were ﬁxed, stained with Giemsa and counted. Each experiment
was repeated at least two times.
Neutral single cell gel electrophoresis (SCGE)
The neutral SCGE (comet assay) was performed as described
(Singh et al, 1988; Olive et al, 1991) with minor modiﬁcations.
Brieﬂy, following treatment and post-treatment incubation, cells
were trypsinized and counted. Ten microlitres of cell suspension
(1610
6 ml
71) were added to 120 ml low melting point agarose
(0.5% in PBS, prewarmed to 378C) and spread onto agarose-coated
(1.5% in PBS) slides. Upon cooling for 10 min at 48C, slides were
submerged in pre-cooled lysis buffer (2.5 M NaCl, 100 mM EDTA,
10 mM Tris-HCl pH 7.5, 1% sodium-lauryl sarcosine; shortly
before use 1 ml Triton X-100 and 10 ml DMSO per 100 ml were
added) for 1 h at 48C. Cells were electrophoresed at 25 V for
exactly 15 min at 48C in electrophoresis buffer (90 mM Tris-HCl,
90 mM boric acid, 2 mM EDTA, pH 7.5). Slides were washed once
in dH2O and ﬁxed in ethanol. After drying, cells were stained with
ethidium bromide (20 mgm l
71) and analyzed microscopically
(Olympus BX50, 1006 magniﬁcation). Olive tail moment was
determined by measuring the ﬂuorescence intensity automatically
using Kinetic Imaging Komet 4.0.2 software (BFI Optilas, Puch-
heim, Germany). Extensive control experiments were performed
in order to calibrate the experimental conditions for speciﬁc detec-
tion of DNA double-strand breaks (Lips and Kaina, 2001, and
unpublished data).
Transfection
CL-V5B cells were tranfected with Effectene (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol. Plasmid
pcDNA3.1-myc-his-bcl-2 is a gift from Dr S Dimmeler (Dimmeler
et al, 1999). Stable transfectants were isolated after 3 weeks of selec-
tion in G418 (800 mgm l
71) and expanded for further analysis.
Western blotting
Pelleted cells were washed once in 100 ml PBS and then soniﬁed in
PBS on ice in a Branson soniﬁer. Cell debris were collected by
centrifugation at 11000 r.p.m. and the supernatant further
processed. Protein determination was performed using the Brad-
ford reagent (BioRad, Munich, Germany). Fifty micrograms of
total protein were loaded onto a 12% SDS gel and, after electro-
phoresis, transferred to Protran
1 nitrocellulose membrane
(Schleicher and Schu ¨ll, Dassel, Germany). After transfer, the
membrane was blocked with 5% dry milk in PBS-T, pH 7.6 with
0.2% Tween-20 for 1 h at room temperature (RT). Incubation with
the primary antibody and the horse raddish-peroxidase-conjugated
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Figure 1 Survival (colony formation) of V79B and CL-V5B cells as a
function of dose of b-D-Glc-IPM. Cells were treated for 1 h with the agent
and ﬁxed 8 days later. Given are mean values from three experiments
+s.d. *, V79; &, CL-V5B.
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Figure 2 Frequency of apoptosis (A) and necrosis (B) of V79B and CL-
V5B cells as a function of dose of b-D-Glc-IPM. Cells were treated for 1 h
and analyzed 72 h post-treatment by FACS. Values are means from three
experiments +s.d. *, V79; &, CL-V5B.
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Washing between each step was performed by shaking the blots
three times in PBS-T for 10 min each wash. All antibodies were
from Santa Cruz Biotechnology (Heidelberg, Germany). After the
ﬁnal wash, detection was performed by enhanced chemolumines-
cence (Amersham, Freiburg, Germany). X-ray ﬁlms were exposed
for 1–2 min.
Detection and quantiﬁcation of apoptosis
Cells were trypsinized, pooled with cells from the supernatant,
centrifuged, washed once with PBS and resuspended in 200 ml
binding buffer (100 mM HEPES pH 7.4, 1.4 mM NaCl, 25 mm
CaCl2, 1% BSA). An aliquot of this suspension was stained with
annexin V (Pharmingen, Heidelberg, Germany) and ethidium
bromide. Cells were analyzed on a ﬂuorescence activated cell sorter
(Becton-Dickinson, Heidelberg, Germany).
Caspase assay
Caspase assays were performed according to the manufacturer’s
protocol (R&D Systems, Wiesbaden, Germany) with minor modi-
ﬁcations. Brieﬂy, cells were lysed in 100 ml lysis buffer and pipetted
in triplicate in 30 ml aliquots onto a 96-well microtiter plate. After
addition of reaction buffer and substrate for caspases-3, -8 and -9,
respectively, and incubation for 1–3 h at 378C, extinction was
measured in an ELISA reader at 405 nm. Controls were cell lysates
containing buffer but without substrate, and substrate containing
buffer without cell lysate.
RESULTS AND DISCUSSION
The cell line CL-V5B is *30-fold more sensitive (based on D10
values) than the parental ‘wild-type’ cell line to the cytotoxic effect
of b-D-Glc-IPM, as measured by loss of colony-forming ability of
the cells (Seker et al, 2000 and Figure 1). To see whether this
hypersensitivity is due to the induction of apoptosis and/or necro-
sis, both endpoints were measured in parallel by annexin V and
propidium iodide double-staining and ﬂow cytometry as previously
described (Ochs and Kaina, 2000). As shown by the dose-response
curves of Figure 2, the frequencies of apoptosis and necrosis were
enhanced in CL-V5B cells compared to the wild-type indicating
that both apoptosis and necrosis can be induced in response to
b-D-Glc-IPM. This is very likely to be due to the formation of
DNA crosslinks to which the cells are hypersensitive (Telleman et
al, 1995). The time-course of induction revealed that apoptosis
occurred not earlier than 2 days after treatment of cells with the
drug and further increased during the post-incubation time up
to 70% (Figure 3A). In contrast to this, the frequency of necrosis
did not exceed 20% and remained rather constant (Figure 3B).
Therefore, apoptosis appears to be the predominant route of cell
killing in CL-V5B cells treated with b-D-Glc-IPM.
In the time-course experiments shown in Figure 3 the drug
concentration was 0.1 mM, which was ineffective to signiﬁcantly
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s
A
p
o
p
t
o
s
i
s
 
(
%
)
80
60
40
20
0
Time (h)
A
02 44 87 2 9 6
40
20
0
N
e
c
r
o
s
i
s
 
(
%
)
B
02 4 4 8 7 2 9 6
Figure 3 Frequency of apoptosis (A) and necrosis (B) in V79B and CL-
V5B cells as a function of time after pulse-treatment with b-D-Glc-IPM. Ex-
ponentially growing cells were treated with a dose of 0.1 mM for 1 h.
Apoptosis and necrosis were measured up to 96 h thereafter. Data of
one representative experiment are shown. *, V79; &, CL-V5B.
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Figure 4 Frequency of apoptosis (A) and necrosis (B) in wild-type V79B
cells as a function of time after treatment with b-D-Glc-IPM with a dose of
0.4 mM for 1 h.
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the dose to 0.4 mM also induced apoptosis and necrosis in the
parental cells (Figure 4A,B). This demonstrates that V79B cells
basically react in the same way as the hypersensitive cells do, albeit
at higher dose level.
Previously we demonstrated that DNA double-strand breaks
(DSBs) trigger very effectively apoptosis (Lips and Kaina, 2001).
Furthermore, we proposed that, in the case of methylating agent-
and UV light-induced apoptosis, DSBs derived from critical
primary lesions activate the apoptotic pathway (Ochs and Kaina,
2000; Ochs et al, 2001; Dunkern et al, 2001a,b). To elucidate
whether DSBs are formed in b-D-Glc-IPM treated cells and
whether parental V79B and CL-V5B cells respond differently, DSBs
were quantiﬁed by means of neutral single cell gel electrophoresis
(SCGE). As shown in Figure 5, DSBs are formed in CL-V5B but
not in V79B cells upon treatment with a dose of 0.15 mM which
is highly effective in inducing apoptosis in CL-V5B but not in
the V79B cells. With the equitoxic dose of 0.4 mM (for comparison
see Figures 2 and 4) DSBs were also generated in V79B cells which
is in accordance with the induction of apoptosis (and necrosis) in
these cells under these treatment conditions (Figure 5).
In various cell systems Bcl-2 has been shown to be critically
involved in DNA damage-induced apoptosis. To see whether b-
D-Glc-IPM affects Bcl-2 expression, we measured the Bcl-2 level
in V79B and CL-V5B cells at various time points after treatment.
As shown in Figure 6, Bcl-2 expression initially decreased in both
cell types after treatment. However, after 24 h Bcl-2 in CL-V5B
cells remained at a reduced level, whereas the expression recovered
in V79B parental cells exceeding even the control level. Since Bcl-2
decline was observed already 24 h after treatment, it clearly
preceded the appearance of apoptotic cells indicating that both
parameters are interrelated. In order to deﬁne more precisely a
critical role of Bcl-2 in modulating the apoptotic pathway, we
stably transfected CL-V5B cells with a Bcl-2 expression plasmid.
As shown in Figure 7, apoptotic cell death induced by b-D-Glc-
IPM was signiﬁcantly reduced compared to cells transfected with
the vector only. This indicates that Bcl-2 decline is causally
involved in b-D-Glc-IPM induced apoptosis. The critical role of
Bcl-2 in b-D-Glc-IPM-induced apoptosis is in line with data
obtained with other repair deﬁcient cell types we have investigated
so far. For example, cells deﬁcient for the repair protein O
6-
methylguanine-DNA methyltransferase (MGMT), which are much
more sensitive than MGMT proﬁcient cells to O
6-methylguanine
generating agents, show dose-dependently decrease in the Bcl-2
expression level (Ochs and Kaina, 2000). Also, base excision repair
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Figure 5 Induction of DNA double-strand breaks in V79B (V79wt) and
CL-V5B. Subconﬂuent cells were pulse-treated for 1 h with 0.15 mM (CL-
V5B) or 0.15 and 0.4 mM (V79wt) b-D-Glc-IPM, respectively. Cells were
analyzed at the indicated times after treatment by neutral SCGE and olive
tail moment is given as mean value +s.d. For each measure point 100 cells
were scored.
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Figure 6 Time course of Bcl-2 expression upon treatment of V79B and
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tative example is shown on top) and quantiﬁcation of Bcl-2 expression
(bottom). Bcl-2 expression was normalized for the expression of ERK-2
and shown as x-fold increase over the control level. Quantitative data
are from three experiments +s.d. *, V79; &, CL-V5B.
A
p
o
p
t
o
s
i
s
 
(
%
)
30
25
20
15
10
5
0
V79 V5B CL-V5B- CL-V5B-
pcDNA3 Bcl-2
b
c
l
-
2
p
c
D
N
A
3
Figure 7 Frequency of apoptosis in IPM-treated (&) and untreated (&)
CL-V5B cells transfected with pcDNA3 vector alone or with myc-his-
tagged bcl-2. Insert: Western blot showing the strong expression Bcl-2
and a mock-transfected clone. Given are mean values from four experi-
ments +s.d.
Glufosfamide-induced apoptosis
R Becker et al
133
ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(1), 130–135defective mouse cells and nucleotide excision repair defective CHO
cells responded with Bcl-2 decline upon alkylating agent and UV
light as well as cisplatin treatment respectively (Dunkern et al,
2001a, b; Ochs et al, submitted). Furthermore, electroporation of
cells with the restriction endonuclease PvuII inducing DSBs caused
Bcl-2 decline that preceded apoptosis (Lips and Kaina, 2001).
Taken together the data strongly suggest that Bcl-2 decline is a
common feature of DNA damage-triggered apoptosis in ﬁbroblasts.
To further elucidate the molecular mechanism of apoptosis, we
investigated the activation of caspases-3, -8 and -9, which are the
major executioners of drug-induced apoptosis in many cell
systems. As shown in Figure 8 all three caspases were dose-depen-
dently activated in the sensitive CL-V5B cells. Time course
experiments revealed that caspase activation occurred 48 h after
treatment with a maximum at 72 h (Figure 9). Strongest induction
of activity was found for caspase-9 (10-fold). At the highest
concentration of b-D-Glu-IPM applied (0.4 mM) caspase-9 was
activated by a factor of 25 and 10 in CL-V5B and V79B cells,
respectively. No signiﬁcant increase in caspase activity was detected
in the resistant parental cell line at a concentration of 0.1 mM.
Therefore the activation of caspase-9 seems to reﬂect the induction
of apoptosis in these cells (compare with Figures 2 and 4). It
should be noted however that unlike DSBs, for which V79B and
CL-V5B cells respond similar at equitoxic doses, activation of
caspases at the respective doses is much weaker in V79B as
compared to CL-V5B cells. Also, caspase activation appears not
to be a linear function of dose as compared to the frequency of
apoptosis. This could be a reﬂection of the ampliﬁcation-based
character of activation of caspases and caspase related functions
(Bratton et al, 2000). The time course and extent of caspase activa-
tion suggests a sequential activation, beginning with the upstream
initiator caspase-9 followed by caspase-3. Interestingly, caspase-8
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Figure 9 Time course of activation of caspase-3 (A), caspase-8 (B) and
caspase-9 (C) upon treatment of V79 and CL-V5B cells with 0.1 mM b-D-
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that caspase-8 is activated via the Fas/CD95 receptor pathway, it
has recently been shown that caspase-8 activation can also occur
receptor-independently upon treatment with anticancer drugs
(Wesselborg et al, 1999). Whether or not the CD95 receptor is
involved in triggering caspase-8 activation in CL-V5B cells is
currently under investigation.
Taken together, our data show that the anticancer drug b-D-
Glc-IPM induces cell killing by activating the apoptotic pathway.
Similarly to data obtained with cisplatin (Dunkern et al, 2001b)
it is hypothesized that primary DNA crosslinking lesions do not
act as a direct trigger of the apoptotic response, but DSBs arising
from them. Necrosis appears to contribute only as a minor fraction
to b-D-Glc-IPM-induced cell death. The results also suggest decline
of Bcl-2 to be causally involved activating the mitochondrial
damage pathway. Since b-D-Glc-IPM basically acts in the same
way as cyclophosphamide and related crosslinking agents, the data
may be taken at the same time to gain insight into the mode of cell
killing provoked by this highly relevant class of anticancer drugs.
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